
Repertoire Genesis
Development of new diagnostic/therapeutic methods based on immune diversity analysis.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
investor investor | €0.0 | round | |
investor investor | €0.0 | round | |
investor | €0.0 | round | |
* | N/A | Acquisition | |
Total Funding | 000k |


Related Content
Repertoire Genesis Inc. is a pioneering biotechnology company focused on developing advanced therapeutic and diagnostic methods by harnessing the power of the immune system. The company collaborates with academia and pharmaceutical firms to create innovative solutions for a wide range of medical applications, including cancer immunotherapy and autoimmune disease management. Repertoire Genesis operates in the global healthcare market, serving patients, research institutions, and pharmaceutical companies. Its business model revolves around proprietary immune diversity analysis technology, which provides accurate and comprehensive data to support medical research, prevention, diagnosis, and treatment. The company generates revenue through research and development agreements, patents, and partnerships with key stakeholders in the healthcare industry.
Keywords: biotechnology, immune system, cancer immunotherapy, autoimmune diseases, diagnostic methods, therapeutic solutions, immune diversity analysis, healthcare, research partnerships, global market.